Randomized, double-Blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm2) in Alzheimers disease

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Cummings, Jeffrey L. (VerfasserIn) , Frölich, Lutz (VerfasserIn)
Dokumenttyp:	Article (Journal)
Sprache:	Englisch
Veröffentlicht:	July 11, 2012
In:	Dementia and geriatric cognitive disorders Year: 2012, Jahrgang: 33, Heft: 5, Pages: 341-353
ISSN:	1421-9824
DOI:	10.1159/000340056
Online-Zugang:	Verlag, Volltext: http://dx.doi.org/10.1159/000340056 Verlag, Volltext: https://www.karger.com/Article/FullText/340056
Verfasserangaben:	Jeffrey Cummings, Lutz Froelich, Sandra E. Black, Serge Bakchine, Giuseppe Bellelli, José L. Molinuevo, Reto W. Kressig, Pamela Downs, Angelika Caputo, Christine Strohmaier

Randomized, double-blind, parallel-group,48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm(2)) in Alzheimer’s disease

in: Dementia and geriatric cognitive disorders

Article (Journal) Book/Monograph Online Resource

in: Dementia and geriatric cognitive disorders, 33 (2012), 5, Seite 341-353

Article (Journal)